🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 36 of 114

  1. Fluticasone propionate pressurized metered dose inhaler

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  2. Fluticasone propionate,Salbutamol sulfate, ProAir® RespiClick®, ProAir® Digihaler®, Fluticasone propionate,Salbutamol sulfate

    Lacuna Pharma Pty Ltd

    Asthma

    phase 3 small molecule active

    1 trial

  3. Fluticasone/ Formoterol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Asthma

    phase 3 small molecule active

    1 trial

  4. Fluzoparib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer Metastatic

    phase 3 small molecule active

    2 trials

  5. Follitropin alfa

    Ferring Pharmaceuticals

    Controlled Ovarian Simulation

    phase 3 small molecule completed

    1 trial

  6. Fordadistrogene Movaparvovec, ECULIZUMAB, Placebo for PF-06939926

    Pfizer Australia Pty Ltd

    DUCHENNE MUSCULAR DYSTROPHY (DMD)

    phase 3 small molecule active

    1 trial

  7. ForeCYTE Breast Aspirator

    ATOSSA THERAPEUTICS, INC.

    Breast Cancer, Preneoplastic Conditions, BRCA

    phase 3 other terminated

    1 trial

  8. Formosa 1-Breath Free (NRICM101)

    Hospital Authority, Hong Kong

    Influenza Viral Infections

    phase 3 small molecule active

    1 trial

  9. Fortecortin® 2 mg Tabletten, Privigen 100 mg/ml solution for infusion, Privigen 100 mg/ml solution for infusion, KIOVIG 100 mg/ml solution for infusion, Imnovid 4 mg hard capsules, Privigen 100 mg/ml solution for infusion, Pomalidomide, KIOVIG 100 mg/ml solution for infusion, Imnovid 1 mg hard capsules, KIOVIG 100 mg/ml solution for infusion, Pomalidomide, Dexamethasone Tablets BP 2.0mg, JNJ-64407564, JNJ-64407564, Pomalidomide, DARZALEX 1800 mg solution for injection, Imnovid 3 mg hard capsules, Dexamethas

    Janssen-Cilag International N.V.

    Relapsed or Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  10. Fortecortin® 2 mg Tabletten, teclistamab, Lenalidomide Mylan 25 mg hard capsules, JNJ-64407564, Dexamethasone Tablets BP 2.0mg, Lenalidomide Accord 10 mg hard capsules, JNJ-64407564, Lenalidomide Mylan 15 mg hard capsules, Lenalidomide Accord 5 mg hard capsules, Dexamethason 4 mg JENAPHARM®, Lenalidomide Mylan 5 mg hard capsules, Privigen 100 mg/ml solution for infusion, DARZALEX 1800 mg solution for injection, Lenalidomide Accord 15 mg hard capsules, Lenalidomide Accord 25 mg hard capsules, Privigen 100 mg

    Janssen-Cilag International N.V.

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  11. Forxiga 10 mg film-coated tablets, Baxdrostat Placebo, Baxdrostat, Baxdrostat, Baxdrostat

    AstraZeneca AB

    Prevention of Heart failure

    phase 3 small molecule active

    1 trial

  12. Fosaprepitant

    The First People's Hospital of Lianyungang

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  13. Fosmanogepix, POSACONAZOLE , AMPHOTERICIN B , CASPOFUNGIN , ISAVUCONAZOLE , MICAFUNGIN , TERBINAFINE , VORICONAZOLE , ANIDULAFUNGIN , -, Fosmanogepix

    Lacuna Pharma Pty Ltd

    Invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or other multidrug resistant molds

    phase 3 small molecule active

    1 trial

  14. Fosmetpantotenate

    Travere Therapeutics

    Pantothenate Kinase-Associated Neurodegeneration

    phase 3 small molecule terminated

    1 trial

  15. Fosrenol (Lanthanum Carbonate)

    Takeda

    Chronic Kidney Disease, Stage 5

    phase 3 small molecule completed

    1 trial

  16. Fostamatinib

    RIGEL PHARMACEUTICALS INC

    Covid19

    phase 3 small molecule completed

    1 trial

  17. Fostamatinib disodium

    RIGEL PHARMACEUTICALS INC

    Warm Antibody Autoimmune Hemolytic Anemia

    phase 3 small molecule active

    2 trials

  18. Fostamatinib disodium

    RIGEL PHARMACEUTICALS INC

    Immune Thrombocytopenic Purpura

    phase 3 small molecule completed

    3 trials

  19. Fp MDPI

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial

  20. Fp/ABS

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    1 trial

  21. Fractional CO2 Laser

    Hospital Authority, Hong Kong

    Treatments of Striae Gravidarum

    phase 3 other active

    1 trial

  22. Fremanezumab

    Teva Pharma GmbH

    Episodic Cluster Headache

    phase 3 small molecule terminated

    1 trial

  23. Fremanezumab

    Teva Pharma GmbH

    Migraine Prophylaxis

    phase 3 small molecule completed

    1 trial

  24. Fremanezumab

    Teva Pharma GmbH

    Chronic Cluster Headache

    phase 3 small molecule terminated

    1 trial

  25. Fremanezumab

    Teva Pharma GmbH

    Cluster Headache

    phase 3 small molecule terminated

    1 trial

  26. Fremanezumab, AJOVY 225 mg solution for injection in pre-filled pen

    Lacuna Pharma Pty Ltd

    Episodic and Chronic Migraine

    phase 3 small molecule active

    1 trial

  27. Frexalimab

    Sanofi-aventis Healthcare Pty Ltd

    Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  28. Fulvestrant

    Novartis Pharmaceuticals

    Metastatic Breast Cancer

    phase 3 small molecule terminated

    1 trial

  29. Fulvestrant

    Novartis Pharmaceuticals

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  30. Fulvestrant combined with Pyrotinib

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Breast Cancer

    phase 3 small molecule active

    1 trial

  31. Furazidin, vaginal tablets, 5mg, Dalacin 20 mg/g hüvelykrém

    Lacuna Pharma Pty Ltd

    Bacterial vaginosis

    phase 3 small molecule active

    1 trial

  32. Furmonertinib, AFATINIB, OSIMERTINIB, OSIMERTINIB, AFATINIB, AFATINIB

    ArriVent BioPharma

    Advanced or Metastatic Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

    phase 3 small molecule active

    1 trial

  33. Futibatinib, FULVESTRANT

    Taiho Pharma Netherlands B.V.

    Malignant Solid Tumors

    phase 3 small molecule active

    1 trial

  34. G-Pen

    Universal Integrated

    Insulin Hypoglycemia

    phase 3 small molecule completed

    1 trial

  35. G-Pen

    Xeris Biopharma Holdings

    Insulin Hypoglycemia

    phase 3 small molecule completed

    1 trial

  36. G-Pen (glucagon injection)

    Xeris Biopharma Holdings

    Hypoglycemia

    phase 3 small molecule completed

    1 trial

  37. G-SCF

    The First People's Hospital of Lianyungang

    Granulocyte Colony-stimulating Factor

    phase 3 small molecule active

    1 trial

  38. GA 20 mg/mL

    Teva Pharma GmbH

    Relapsing-Remitting Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  39. GA-GCB (velaglucerase alfa)

    Takeda

    Gaucher Disease

    phase 3 mab completed

    1 trial

  40. GABITRIL (tiagabine hydrochloride; CEP-6671)

    Teva Pharma GmbH

    General Anxiety Disorder

    phase 3 small molecule completed

    1 trial

  41. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc Medicine

    Endometrial cancer, uterine cancer

    phase 3 small molecule active

    1 trial

  42. GALLIUM (68GA) CHLORIDE, TILMANOCEPT

    Disc Medicine

    Carcinoma of the parotid gland

    phase 3 small molecule active

    1 trial

  43. GALLIUM (68GA) GOZETOTIDE , Zr-DFO-girentuximab, Gallium (68Ga) PSMA-11 (gozetotide) prepared using PSMA-11 Sterile Cold Kit

    Disc Medicine

    Metastatic renal cell carcinoma

    phase 3 small molecule active

    1 trial

  44. GB-0895

    Generate Biomedicines

    Severe Asthma

    phase 3 small molecule active

    2 trials

  45. GC1107

    Green Valley (Shanghai) Pharmaceuticals Co.,

    Bacterial Infections

    phase 3 mab completed

    1 trial

  46. GC4419 90mg

    Galera Therapeutics

    Oral Mucositis

    phase 3 small molecule completed

    1 trial

  47. GCSF

    Hospital Authority, Hong Kong

    End Stage Liver Disease

    phase 3 small molecule active

    1 trial

  48. GEMCI-cell® 38 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Cisplatin NeoCorp 1 mg/ml - Konzentrat zur Herstellung einer Infusionslösung, Gemcitabine 1 g Powder for Solution for Infusion, Gemcitabine 38 mg/ml Concentrate for Solution for Infusion, CISPLATIN-EBEWE, 1 MG/ML, KONCENTRAT DO SPORZĄDZANIA ROZTWORU DO INFUZJI, Carbomedac® 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung, Carboplatin Bendalis 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung, CARBO-cell® 10 mg/ml Infusio

    Bristol-Myers Squibb Australia Pty Ltd

    Untreated Unresectable or Metastatic Urothelial Cancer

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.